Offsetting Assets and Liabilities (Tables)

12 Months Ended

Dec. 31, 2024

Offsetting [Abstract]

Schedule of Offsetting Assets

The composition of offsetting derivative instruments, financial assets, and financial liabilities was as follows.

	Gross amounts of recognized assets/liabilities		Gross amounts offset on the Consolidated Balance Sheet		Net amounts of assets/liabilities presented on the Consolidated Balance Sheet		Gross amounts not offset on the Consolidated Balance Sheet
December 31, ($ in millions)							Financial instruments		Collateral (a) (b) (c)		Net amount
2024
Assets
Derivative assets (d)	$	12	$	—	$	12	$	—	$	(10)	$	2
Total assets	$	12	$	—	$	12	$	—	$	(10)	$	2
Liabilities
Derivative liabilities (e)	$	4	$	—	$	4	$	—	$	—	$	4
Total liabilities	$	4	$	—	$	4	$	—	$	—	$	4
2023
Assets
Derivative assets (d)	$	33	$	—	$	33	$	—	$	(31)	$	2
Total assets	$	33	$	—	$	33	$	—	$	(31)	$	2
Liabilities
Derivative liabilities (e)	$	17	$	—	$	17	$	—	$	(6)	$	11
Securities sold under agreements to repurchase (f)	747		—		747		—		(747)		—
Total liabilities	$	764	$	—	$	764	$	—	$	(753)	$	11

(a)Financial collateral received or pledged shown as a balance based on the sum of all net asset and liability positions between Ally and each individual derivative counterparty.

(b)Amounts disclosed are limited to the financial asset or liability balance and, accordingly, exclude excess collateral received or pledged and noncash collateral received. We do not record noncash collateral received on our Consolidated Balance Sheet unless certain conditions are met.

(c)Certain agreements grant us the right to sell or pledge the noncash assets we receive as collateral. We have not sold or pledged any of the noncash collateral received under these agreements.

(d)Includes derivative assets with no offsetting arrangements of $1 million and $2 million as of December 31, 2024, and December 31, 2023, respectively.

(e)Includes derivative liabilities with no offsetting arrangements of $4 million and $10 million as of December 31, 2024, and December 31, 2023, respectively.

(f)For additional information on securities sold under agreements to repurchase, refer to Note 15.

Schedule of Offsetting Liabilities

The composition of offsetting derivative instruments, financial assets, and financial liabilities was as follows.

	Gross amounts of recognized assets/liabilities		Gross amounts offset on the Consolidated Balance Sheet		Net amounts of assets/liabilities presented on the Consolidated Balance Sheet		Gross amounts not offset on the Consolidated Balance Sheet
December 31, ($ in millions)							Financial instruments		Collateral (a) (b) (c)		Net amount
2024
Assets
Derivative assets (d)	$	12	$	—	$	12	$	—	$	(10)	$	2
Total assets	$	12	$	—	$	12	$	—	$	(10)	$	2
Liabilities
Derivative liabilities (e)	$	4	$	—	$	4	$	—	$	—	$	4
Total liabilities	$	4	$	—	$	4	$	—	$	—	$	4
2023
Assets
Derivative assets (d)	$	33	$	—	$	33	$	—	$	(31)	$	2
Total assets	$	33	$	—	$	33	$	—	$	(31)	$	2
Liabilities
Derivative liabilities (e)	$	17	$	—	$	17	$	—	$	(6)	$	11
Securities sold under agreements to repurchase (f)	747		—		747		—		(747)		—
Total liabilities	$	764	$	—	$	764	$	—	$	(753)	$	11

(a)Financial collateral received or pledged shown as a balance based on the sum of all net asset and liability positions between Ally and each individual derivative counterparty.

(b)Amounts disclosed are limited to the financial asset or liability balance and, accordingly, exclude excess collateral received or pledged and noncash collateral received. We do not record noncash collateral received on our Consolidated Balance Sheet unless certain conditions are met.

(c)Certain agreements grant us the right to sell or pledge the noncash assets we receive as collateral. We have not sold or pledged any of the noncash collateral received under these agreements.

(d)Includes derivative assets with no offsetting arrangements of $1 million and $2 million as of December 31, 2024, and December 31, 2023, respectively.

(e)Includes derivative liabilities with no offsetting arrangements of $4 million and $10 million as of December 31, 2024, and December 31, 2023, respectively.

(f)For additional information on securities sold under agreements to repurchase, refer to Note 15.